Literature DB >> 18641049

Renal activity of Akt kinase in obese Zucker rats.

Jana Zdychová1, Ludmila Kazdová, Terezie Pelikanová, Jessie N Lindsley, Sharon Anderson, Radko Komers.   

Abstract

Insulin resistance (IR) and consequent hyperinsulinemia are hallmarks of Type 2 diabetes (DM2). Akt kinase (Akt) is an important molecule in insulin signaling, implicated in regulation of glucose uptake, cell growth, cell survival, protein synthesis, and endothelial nitric oxide (NO) production. Impaired Akt activation in insulin-sensitive tissues contributes to IR. However, Akt activity in other tissues, particularly those affected by complications of DM2, has been less studied. We hypothesized that hyperinsulinemia could have an impact on activity of Akt and its effectors involved in regulation of renal morphology and function in DM2. To address this issue, renal cortical Akt was determined in obese Zucker rats (ZO), a model of DM2, and lean controls (ZL). We also studied expression and phosphorylation of the mammalian target of rapamycin (mTOR) and endothelial NO synthase (eNOS), molecules downstream of Akt in the insulin signaling cascade, and documented modulators of renal injury. Akt activity was measured by a kinase assay with GSK-3 as a substrate. Expression of phosphorylated (active) and total proteins was measured by immunoblotting and immunohistochemistry. Renal Akt activity was increased in ZO as compared to ZL rats, in parallel with progressive hyperinsulinemia. No differences in Akt were observed in the skeletal muscle. Corresponding to increases in Akt activity, ZO rats demonstrated enhanced phosphorylation of renal mTOR. Acute PI3K inhibition with wortmannin (100 mug/kg) attenuated renal Akt and mTOR activities in ZO, but not in ZL rats. In contrast to mTOR, eNOS phosphorylation was similar in ZO and ZL rats, despite higher total eNOS expression. In conclusion, ZO rats demonstrated increases in renal Akt and mTOR activity and expression. However, eNOS phosphorylation did not follow this pattern. These data suggest that DM2 is associated with selective IR in the kidney, allowing pro-growth signaling via mTOR, whereas potentially protective effects mediated by eNOS are blunted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641049     DOI: 10.3181/0801-RM-29

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  9 in total

1.  Salt sensitivity of nitric oxide generation and blood pressure in mice with targeted knockout of the insulin receptor from the renal tubule.

Authors:  Lijun Li; R Mayuri Garikepati; Susanna Tsukerman; S Tiwari; Carolyn M Ecelbarger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-18       Impact factor: 3.619

2.  Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes.

Authors:  Radko Komers; Bei Xu; Jennifer Schneider; Terry T Oyama
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

Review 3.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

4.  Enhanced phosphorylation of Na(+)-Cl- co-transporter in experimental metabolic syndrome: role of insulin.

Authors:  Radko Komers; Shaunessy Rogers; Terry T Oyama; Bei Xu; Chao-Ling Yang; James McCormick; David H Ellison
Journal:  Clin Sci (Lond)       Date:  2012-12       Impact factor: 6.124

5.  Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B.

Authors:  Saurabh Sharma; Manjeet Singh; Pyare Lal Sharma
Journal:  Mol Cell Biochem       Date:  2010-11-11       Impact factor: 3.396

6.  Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat.

Authors:  Anjaiah Katta; Sunil Kakarla; Miaozong Wu; Satyanarayana Paturi; Murali K Gadde; Ravikumar Arvapalli; Madhukar Kolli; Kevin M Rice; Eric R Blough
Journal:  Exp Diabetes Res       Date:  2010-03-30

7.  Development of a peptidase-resistant substrate for single-cell measurement of protein kinase B activation.

Authors:  Angela Proctor; Qunzhao Wang; David S Lawrence; Nancy L Allbritton
Journal:  Anal Chem       Date:  2012-08-09       Impact factor: 6.986

8.  High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach.

Authors:  Elias N Katsoulieris; Garyfalia I Drossopoulou; Eleni S Kotsopoulou; Dimitrios V Vlahakos; Elias A Lianos; Effie C Tsilibary
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

9.  DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.

Authors:  Ravi Nistala; Javad Habibi; Annayya Aroor; James R Sowers; Melvin R Hayden; Alex Meuth; William Knight; Tamara Hancock; Thomas Klein; Vincent G DeMarco; Adam Whaley-Connell
Journal:  Obesity (Silver Spring)       Date:  2014-07-04       Impact factor: 5.002

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.